ES8504458A1 - Procedimiento para producir la subunidad a la toxina del colera. - Google Patents

Procedimiento para producir la subunidad a la toxina del colera.

Info

Publication number
ES8504458A1
ES8504458A1 ES522566A ES522566A ES8504458A1 ES 8504458 A1 ES8504458 A1 ES 8504458A1 ES 522566 A ES522566 A ES 522566A ES 522566 A ES522566 A ES 522566A ES 8504458 A1 ES8504458 A1 ES 8504458A1
Authority
ES
Spain
Prior art keywords
dna
units
preparation
unit
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES522566A
Other languages
English (en)
Other versions
ES522566A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline RIT
Original Assignee
SmithKline RIT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline RIT filed Critical SmithKline RIT
Publication of ES522566A0 publication Critical patent/ES522566A0/es
Publication of ES8504458A1 publication Critical patent/ES8504458A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/848Escherichia
    • Y10S435/849Escherichia coli
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/909Vibrio

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PROCEDIMIENTO PARA PRODUCIR LA SUBUNIDAD A DE LA TOXINA DEL COLERA.CONSISTE EN: A) PROPORCIONAR UNA MOLECULA DE ADN RECOMBINANTE QUE CONTIENE UNA SECUENCIA DE ADN QUE COMPRENDE UNA PORCION QUE CODIFICA LA TOTALIDAD O PARTE DE LA SUBUNIDAD A DE LA TOXINA DEL COLERA MEDIANTE DIGESTION DE ADN DE UNA CEPA DE V. CHOLERAE, PRODUCTORA DE LA SUBUNIDAD A DE LA TOXINA DEL COLERA CON LA ENDONUCLEASA CLAI; B) AISLAR UN FRAGMENTO QUE TIENE HIBRIDACION ESPECIFICA A UNA SONDA ELTA; C) MEZCLAR DICHO FRAGMENTO CON UN VECTOR QUE TIENE UN SITIO DE RESTRICCION POR ENDONUCLEASA CLAI Y PREVIAMENTE DIGERIDO POR DICHA CLAI E INSERTAR EL FRAGMENTO; D) TRANSFORMAR UN ORGANISMO HOSPEDANTE APROPIADO CON DICHA MOLECULA DE ADN RECOMBINANTE; E) CULTIVAR EL ORGANISMO HOSPEDANTE TRANSFORMADO; Y F) RECOGER DICHA SUBUNIDAD A DE LA TOXINA DEL COLERA.
ES522566A 1982-05-24 1983-05-20 Procedimiento para producir la subunidad a la toxina del colera. Expired ES8504458A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/381,083 US4666837A (en) 1982-05-24 1982-05-24 DNA sequences, recombinant DNA molecules and processes for producing the A and B subunits of cholera toxin and preparations containing so-obtained subunit or subunits

Publications (2)

Publication Number Publication Date
ES522566A0 ES522566A0 (es) 1985-04-16
ES8504458A1 true ES8504458A1 (es) 1985-04-16

Family

ID=23503587

Family Applications (3)

Application Number Title Priority Date Filing Date
ES522566A Expired ES8504458A1 (es) 1982-05-24 1983-05-20 Procedimiento para producir la subunidad a la toxina del colera.
ES529276A Expired ES8504460A1 (es) 1982-05-24 1984-01-30 Procedimiento para producir la totalidad o parte de las subunidades a y b de la toxina del colera
ES535809A Granted ES535809A0 (es) 1982-05-24 1984-09-11 Procedimiento para producir la subunidad b de la toxina del colera

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES529276A Expired ES8504460A1 (es) 1982-05-24 1984-01-30 Procedimiento para producir la totalidad o parte de las subunidades a y b de la toxina del colera
ES535809A Granted ES535809A0 (es) 1982-05-24 1984-09-11 Procedimiento para producir la subunidad b de la toxina del colera

Country Status (10)

Country Link
US (1) US4666837A (es)
EP (1) EP0095452A3 (es)
JP (1) JPS58222033A (es)
AU (1) AU1348083A (es)
CA (1) CA1212640A (es)
DK (1) DK211483A (es)
ES (3) ES8504458A1 (es)
GR (1) GR79261B (es)
PT (1) PT76726B (es)
ZA (1) ZA833662B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5882653A (en) * 1983-03-04 1999-03-16 The University Of Maryland System Vibrio cholerae 01 (CVD111) and non-01 (CVD112 and CVD112RM) serogroup vaccine strains, methods of making same and products thereof
US4935364A (en) * 1983-03-04 1990-06-19 Swiss Serum And Vaccine Institute Berne Method of isolating restriction fragment deletions in vibrio cholerae and products thereof
US5470729A (en) * 1983-03-04 1995-11-28 University Of Maryland At Baltimore Method of isolating restriction fragment deletions in Vibrio cholerae, and products thereof
US5399494A (en) * 1983-03-04 1995-03-21 The University Of Maryland System Vibrio cholerae strain CVD103Hgr, method of making same, and vaccines derived therefrom
US4882278A (en) * 1983-04-29 1989-11-21 President And Fellows Of Harvard College Non-toxinogenic vibrio cholerae mutants
GB8333131D0 (en) * 1983-12-12 1984-01-18 Glaxo Group Ltd Microbiological process
AU589114B2 (en) * 1984-02-01 1989-10-05 Enterovax Limited Genetically engineered bacteria useful as a vaccine
US5668255A (en) * 1984-06-07 1997-09-16 Seragen, Inc. Hybrid molecules having translocation region and cell-binding region
US6022950A (en) * 1984-06-07 2000-02-08 Seragen, Inc. Hybrid molecules having translocation region and cell-binding region
CA1340372C (en) * 1984-07-09 1999-02-02 John D. Clements Production of e. coli lt-b enterotoxin subunit
US5308835A (en) * 1984-07-09 1994-05-03 Praxis Biologics, Inc. Production of the E. coli LT-B enterotoxin subunit
US4808700A (en) * 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
US5258498A (en) * 1987-05-21 1993-11-02 Creative Biomolecules, Inc. Polypeptide linkers for production of biosynthetic proteins
DE3853515T3 (de) * 1987-05-21 2005-08-25 Micromet Ag Multifunktionelle proteine mit vorbestimmter zielsetzung.
US5132405A (en) * 1987-05-21 1992-07-21 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
US5091513A (en) * 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
US6043057A (en) * 1988-09-16 2000-03-28 Vitec Aktiebolag Recombinant systems for expression of the cholera B-sub-unit with the aid of foreign promoters and/or leader peptides
SE462285B (sv) * 1988-09-16 1990-05-28 Jan Roland Holmgren Expression av koleratoxinets bindande subenhet med hjaelp av fraemmande promotor- och/eller ledarpeptidstrukturer
FR2636842B1 (fr) * 1988-09-27 1994-06-10 Liege Universite Etat Proteine de fusion d'une sequence derivee de la sous-unite b de la toxine cholerique et d'un antigene heterologue doue de proprietes immunogenes, compositions de vaccins les contenant et acides nucleiques recombinants contenant une sequence de nucleotides codant pour ladite proteine de fusion
US20040014068A1 (en) * 1988-10-05 2004-01-22 Whatman, Inc. Solid medium and method for DNA storage
US5985327A (en) * 1988-10-05 1999-11-16 Flinders Technologies Pty. Ltd. Solid medium and method for DNA storage
JPH05502880A (ja) * 1989-12-22 1993-05-20 セラジェン・インコーポレーテッド トランスロケーション領域および細胞結合領域を有するハイブリッド分子
IL101715A (en) * 1991-05-02 2005-06-19 Amgen Inc Recombinant dna-derived cholera toxin subunit analogs
IT1253009B (it) * 1991-12-31 1995-07-10 Sclavo Ricerca S R L Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
GB9513371D0 (en) * 1995-06-30 1995-09-06 Biocine Spa Immunogenic detoxified mutant toxins
USH1985H1 (en) 1992-01-09 2001-08-07 The United States Of America As Represented By The Secretary Of The Navy Method for detecting biological toxins
JP3134907B2 (ja) * 1993-06-15 2001-02-13 株式会社島津製作所 コレラ菌検出用オリゴヌクレオチドおよびそれを用いた検出法
GB9326174D0 (en) * 1993-12-22 1994-02-23 Biocine Sclavo Mucosal adjuvant
US5773003A (en) * 1995-03-31 1998-06-30 Immulogic, Inc. Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
US20020032316A1 (en) * 1995-03-31 2002-03-14 Cantab Pharmaceuticals Research Limited Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
ATE254930T1 (de) * 1995-03-31 2003-12-15 Xenova Res Ltd Hapten-träger-konjugate zur anwendung in der drogen-missbrauchs-therapie
US6818222B1 (en) 1997-03-21 2004-11-16 Chiron Corporation Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
US7097845B2 (en) 1997-04-23 2006-08-29 Jacob Sten Petersen Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
US6232082B1 (en) 1998-12-01 2001-05-15 Nabi Hapten-carrier conjugates for treating and preventing nicotine addiction
US20030162733A1 (en) * 2000-11-27 2003-08-28 Haynes Joel R. Nucleic acid adjuvants
AU2002252378B2 (en) 2001-03-19 2007-10-18 Intercell Usa, Inc. Transcutaneous immunostimulation
US20060099229A1 (en) * 2004-11-05 2006-05-11 Universiti Sains Malaysia Vibrio cholerae strains VCUSM1 and VCUSM4, method of producing same, and vaccine derivatives thereof
WO2014044690A1 (en) 2012-09-18 2014-03-27 Valneva Austria Gmbh Improved vaccines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366246A (en) * 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
US4264737A (en) * 1978-09-21 1981-04-28 President And Fellows Of Harvard College Method of making genetically stable mutants of vibrio cholerae
US4332892A (en) * 1979-01-15 1982-06-01 President And Fellows Of Harvard College Protein synthesis
US4328209A (en) * 1979-04-11 1982-05-04 Board Of Regents, The University Of Texas System Cholera vaccine
US4293652A (en) * 1979-05-25 1981-10-06 Cetus Corporation Method for synthesizing DNA sequentially
US4338397A (en) * 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis

Also Published As

Publication number Publication date
ES522566A0 (es) 1985-04-16
ES8506348A1 (es) 1985-07-01
US4666837A (en) 1987-05-19
EP0095452A3 (en) 1985-10-02
DK211483A (da) 1983-11-25
DK211483D0 (da) 1983-05-11
ES535809A0 (es) 1985-07-01
EP0095452A2 (fr) 1983-11-30
CA1212640A (en) 1986-10-14
AU1348083A (en) 1983-12-01
JPS58222033A (ja) 1983-12-23
GR79261B (es) 1984-10-22
PT76726B (en) 1985-12-27
ZA833662B (en) 1984-03-28
PT76726A (en) 1983-06-01
ES529276A0 (es) 1985-05-01
ES8504460A1 (es) 1985-05-01

Similar Documents

Publication Publication Date Title
ES8506348A1 (es) Procedimiento para producir la subunidad b de la toxina del colera
AU1672388A (en) Expression of human proapolipoprotein a-i
UA43314C2 (uk) Фрагмент виділеної днк, що кодує дельта-6-десатуразу ціанобактерій (варіанти), вектор, спосіб одержання рослини з підвищеним вмістом гамма-ліноленової кислоти (варіанти), спосіб індукування продукції гамма-ліноленової кислоти (варіанти), спосіб індукування продукції октадекатетраєнової кислоти (варіанти) та ціанобактеріальна дельта-6-десатураза
EP0088195A3 (en) Messenger rna, production and use thereof
ES8603578A1 (es) Procedimiento para preparar acido hialuronico
MD430C2 (ro) Procedeu de obţinere a interferonelor leucocitare umane
IL88151A (en) Interleukin-7 protein, dna sequences encoding it, its preparation and compositions containing it
AU6745287A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
AU6724794A (en) GRB3-3 gene, its variants and their uses
NZ307444A (en) Polyphenol oxidase genes from lettuce and banana
AU5437390A (en) Methods and nucleic acid sequences for the expression of the cellulose synthase operon
GR862448B (en) Kibdelosporangium aridum sk & f-aad-609
AUPM772494A0 (en) Improvements in production of proteins in host cells
EP0220714A3 (en) Dna fragment containing the cyclodextrin-glycosyl-transferase gene, expression vector, microorganisms for expression and preparation process
AU8107094A (en) Endothelin-converting enzyme
GB9321302D0 (en) Enzyme
WO1993018151A1 (fr) Element transposable originaire d'une bacterie du genre brevibacterium
ES8502162A1 (es) Procedimiento para preparar un hidrolizado proteinico
WO1994011518A3 (en) Methods for converting a, ab, and b blood types to o blood type
HU911770D0 (en) Process for isolating and expressing gene coding streptokynase, the recombinant dna of coding nucleotide sequence and transformed microorganisms
AU682278B2 (en) Oligomer carrier molecules in which marker groups and haptens are selectively incorporated